Healthcare · head to head
Annalise.ai vs Fujifilm Synapse

Annalise.ai
Healthcare
Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model
- From
- On request
- Rated
- -

Fujifilm Synapse
Healthcare
Enterprise imaging platform covering PACS, VNA, cardiology and 3D from Fujifilm Healthcare
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.; Fujifilm Synapse pACS, VNA, Cardiovascular and 3D are separately licensed and separately versioned, so an enterprise deployment means four upgrade cycles and four support relationships under one brand rather than one platform upgrade.
- They diverge on capability: Annalise.ai covers Annalise Enterprise CXR, Fujifilm Synapse covers Synapse PACS.
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which Annalise.ai and Fujifilm Synapse actually diverge.
| Attribute | Annalise.ai | Fujifilm Synapse |
|---|---|---|
| Platforms | Web, Cloud, On-premise | Web, Windows, iOS, Android |
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Annalise.ai
- Annalise Enterprise CXR
- Annalise Enterprise CTB
- Triage and notification
- Worklist reprioritisation
- Localisation overlays
- Confidence output
- PACS-native deployment
- On-premise or cloud inference
Only in Fujifilm Synapse
- Synapse PACS
- Synapse VNA
- Synapse Cardiovascular
- Synapse 3D
- Synapse Mobility
- Deconstructed PACS support
- Cloud services
What people use each for
The jobs each tool is most often brought in to do.
Annalise.ai
- An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Fujifilm Synapse
- A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Fujifilm Synapse
- A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Fujifilm Synapse
- A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Fujifilm Synapse
Fujifilm Synapse
- A hospital replacing PACS that wants the archive decoupled from its scanner vendor so future modality purchases stay competitivenot Annalise.ai
- A health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policynot Annalise.ai
- An outpatient imaging chain that needs one worklist across multiple sites and radiologists reading remotelynot Annalise.ai
- A site pursuing a deconstructed PACS strategy that wants to replace the viewer later without touching the archivenot Annalise.ai
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Annalise.ai
- The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
- Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
- Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
- The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
- A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.
Fujifilm Synapse
- PACS, VNA, Cardiovascular and 3D are separately licensed and separately versioned, so an enterprise deployment means four upgrade cycles and four support relationships under one brand rather than one platform upgrade.
- Synapse 3D is licensed by concurrent user and sized from average concurrency, which leaves radiologists queued for advanced visualisation at the morning reading peak and forces an unplanned licence purchase.
- As an independent informatics vendor Fujifilm has less privileged access to proprietary modality data than Philips or Siemens have on their own scanners, so some vendor specific post processing is not available.
- The vendor neutral archive absorbs non DICOM object types only after per specialty configuration work, and departments such as ophthalmology and dermatology usually need bespoke ingestion projects that were not in the original scope.
- Migrating a decade of priors from a legacy archive is a large professional services line that Fujifilm quotes separately, and these migrations regularly run past the contracted go live date.
Pricing, plan by plan
Annalise.ai
On request- Annalise Enterprise$undefined/year
- Priced per study analysed or as an annual volume subscription
- CXR and CTB licensed separately
- Cleared finding set differs by market, which changes what you are buying
Fujifilm Synapse
On request- Synapse$undefined/year
- Each module licensed separately: PACS, VNA, Cardiovascular, 3D
- Priced by annual study volume and concurrent diagnostic users
- Synapse 3D licensed by concurrent user, separate from PACS
Which should you pick?
Choose Annalise.ai if
- You need annalise enterprise cxr.
- You work on Web, Cloud, On-premise.
- You also want annalise enterprise ctb.
Choose Fujifilm Synapse if
- You need synapse pacs.
- You work on Web, Windows, iOS, Android.
- You also want synapse vna.
Questions people ask
- Is Annalise.ai or Fujifilm Synapse better?
- Neither clearly leads. Annalise.ai starts at On request and Fujifilm Synapse at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Annalise.ai or Fujifilm Synapse?
- Annalise.ai starts at On request and Fujifilm Synapse at On request.
- Does Annalise.ai or Fujifilm Synapse run on more platforms?
- Annalise.ai runs on Web, Cloud, On-premise. Fujifilm Synapse runs on Web, Windows, iOS, Android.
- What is Annalise.ai best used for?
- Annalise.ai is most often used for an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest, a teleradiology provider covering many small hospitals that needs consistent triage before a human reads, a screening programme in europe where the broader ce marked decision support indication, rather than the narrow united states triage clearance, is what is being deployed, a radiology department building an ai governance programme that wants one vendor covering both chest radiograph and head ct rather than contracting two separate algorithm suppliers. Of those, an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest and a teleradiology provider covering many small hospitals that needs consistent triage before a human reads are not what Fujifilm Synapse is typically brought in for.
- What can Annalise.ai do that Fujifilm Synapse cannot?
- Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation. Fujifilm Synapse covers Synapse PACS, Synapse VNA, Synapse Cardiovascular, Synapse 3D.
Answered from the vendors’ own pages
Annalise.ai: How many findings are FDA cleared?
Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.
Fujifilm Synapse: Is Synapse one product or several?
Several. Synapse PACS, Synapse VNA, Synapse Cardiovascular and Synapse 3D are separately licensed products under one brand. Price and scope each one individually.
Annalise.ai: Is the European position different?
Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.
Fujifilm Synapse: Do I have to buy Fujifilm scanners?
No. Fujifilm sells Synapse independently of imaging hardware, which is a large part of why it wins competitive PACS replacements at mixed fleet sites.
Annalise.ai: Does it diagnose?
No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.
Fujifilm Synapse: Does Synapse publish pricing?
No. Pricing is quoted by study volume, concurrent users, module mix and storage capacity.
Annalise.ai: Is Annalise.ai becoming Harrison.ai?
The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.
Fujifilm Synapse: Can Synapse VNA store non radiology images?
Yes, including visible light, ophthalmology and wound photography, but each specialty typically needs its own ingestion and metadata configuration project.
Related pages
More on Annalise.ai
More on Fujifilm Synapse
Other head to heads
- Annalise.ai vs Gleamer
- Annalise.ai vs Rad AI
- Annalise.ai vs Sectra
- Annalise.ai vs Aidoc
- Annalise.ai vs Ibex Medical Analytics
- Annalise.ai vs Paige
- Annalise.ai vs Philips IntelliSpace PACS
- Annalise.ai vs Visage Imaging
- Annalise.ai vs Lunit
- Annalise.ai vs Techcyte
- Annalise.ai vs PathAI
- Annalise.ai vs Epocrates
- Annalise.ai vs Figure 1
- Annalise.ai vs Fullscript
- Annalise.ai vs GNU Health
- Annalise.ai vs GoodRx
- Annalise.ai vs Halaxy
- Annalise.ai vs Ambra Health
- Annalise.ai vs Epic Systems
- Annalise.ai vs Nookal
- Annalise.ai vs Flo
- Annalise.ai vs Talkspace
- Annalise.ai vs Practice Fusion
- Annalise.ai vs Ro
- Annalise.ai vs RXNT
- Annalise.ai vs Signant Health
- Annalise.ai vs Sysmex
- Fujifilm Synapse vs Gleamer
- Fujifilm Synapse vs Rad AI
- Fujifilm Synapse vs Sectra
- Fujifilm Synapse vs Aidoc
- Fujifilm Synapse vs Ibex Medical Analytics
- Fujifilm Synapse vs Paige
- Fujifilm Synapse vs Philips IntelliSpace PACS
- Fujifilm Synapse vs Visage Imaging
- Fujifilm Synapse vs Lunit
- Fujifilm Synapse vs Techcyte
- Fujifilm Synapse vs PathAI
- Fujifilm Synapse vs Epocrates
- Fujifilm Synapse vs Figure 1
- Fujifilm Synapse vs Fullscript
- Fujifilm Synapse vs GNU Health
- Fujifilm Synapse vs GoodRx
- Fujifilm Synapse vs Halaxy
- Fujifilm Synapse vs Ambra Health
- Fujifilm Synapse vs Epic Systems
- Fujifilm Synapse vs Nookal
- Fujifilm Synapse vs Flo
- Fujifilm Synapse vs Talkspace
- Fujifilm Synapse vs Practice Fusion
- Fujifilm Synapse vs Ro
- Fujifilm Synapse vs RXNT
- Fujifilm Synapse vs Signant Health
- Fujifilm Synapse vs Sysmex
